Revenue (Tables)

3 Months Ended

Mar. 31, 2023

Revenue from Contract with Customer [Abstract]

Summary of Disaggregation of Revenue

The Company categorizes revenue based on various factors such as the nature of contracts, payors, order to billing arrangements, and cash flows received by the Company, as follows:

(in thousands)	Three Months Ended March 31,
	2023		2022
Patient services
Capitated revenue	$	16,568	$	14,516
FFS revenue	33,705		20,541
Subtotal	50,273		35,057
Dispensary revenue	24,240		18,679
Clinical research trials and other revenue	1,679		1,425
Total	$	76,192	$	55,161